| Bunkie General Hospital | |
| 427 Evergreen Street, Bunkie, Louisiana 71322 | |
| (318) 346-6681 | |
| Not Available |
| Name | Bunkie General Hospital |
|---|---|
| Type | Critical Access Hospital |
| Location | 427 Evergreen Street, Bunkie, Louisiana |
| Ownership | Government - Hospital District or Authority |
| Emergency Services | Yes |
| Medicare ID (CCN) | 191311 |
| NPI Number | 1316157845 |
| Organization Name | HOSPITAL SERVICE DISTRICT NO 1 PARISH OF AVOYELLES STATE OF LOUISIANA |
| Address | 427 Evergreen St, Bunkie, LA 71322 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 318-346-6681 |
News Archive
Antibiotic-resistant Pseudomonas infections in cystic fibrosis patients show predictable sensitivities to other classes of antibiotics.
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis.
Innovent Biologics, Inc., a privately held Chinese biopharmaceutical company dedicated to the development and manufacturing of complex, high-end biologics to be marketed in the rapidly growing Chinese market and elsewhere worldwide that meet EMEA and FDA/cGMP standards, has raised $100 million in Series C financing.
A study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type 2 diabetes.
› Verified 7 days ago
| NPI Number | 1639377294 |
| Organization Name | BUNKIE GENERAL HOSPITAL |
| Address | 427 Evergreen St, Bunkie, LA 71322 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 318-346-6681 |
News Archive
Antibiotic-resistant Pseudomonas infections in cystic fibrosis patients show predictable sensitivities to other classes of antibiotics.
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis.
Innovent Biologics, Inc., a privately held Chinese biopharmaceutical company dedicated to the development and manufacturing of complex, high-end biologics to be marketed in the rapidly growing Chinese market and elsewhere worldwide that meet EMEA and FDA/cGMP standards, has raised $100 million in Series C financing.
A study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type 2 diabetes.
› Verified 7 days ago
| NPI Number | 1710932470 |
| Organization Name | HOSPITAL SERVICE DISTRICT NO1 PARISH OF AVOYELLES STATE OF LOUISIANA |
| Address | 427 Evergreen St, Bunkie, LA 71322 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 318-346-6681 |
News Archive
Antibiotic-resistant Pseudomonas infections in cystic fibrosis patients show predictable sensitivities to other classes of antibiotics.
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis.
Innovent Biologics, Inc., a privately held Chinese biopharmaceutical company dedicated to the development and manufacturing of complex, high-end biologics to be marketed in the rapidly growing Chinese market and elsewhere worldwide that meet EMEA and FDA/cGMP standards, has raised $100 million in Series C financing.
A study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type 2 diabetes.
› Verified 7 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
Antibiotic-resistant Pseudomonas infections in cystic fibrosis patients show predictable sensitivities to other classes of antibiotics.
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON Delayed-Release Capsules to treat exocrine pancreatic insufficiency (EPI) due to cystic fibrosis.
Innovent Biologics, Inc., a privately held Chinese biopharmaceutical company dedicated to the development and manufacturing of complex, high-end biologics to be marketed in the rapidly growing Chinese market and elsewhere worldwide that meet EMEA and FDA/cGMP standards, has raised $100 million in Series C financing.
A study of approximately 200,000 blood samples from the UK Biobank has identified more than 2,000 undiagnosed cases of type 2 diabetes.
› Verified 7 days ago
Bunkie General Hospital Critical Access Hospital Location: 427 Evergreen Street, Bunkie, Louisiana 71322 Phone: (318) 346-6681 | |
Beacon Behavioral Hospital - Central Psychiatric Hospital Location: 323 Evergreen Street, Bunkie, Louisiana 71322 Phone: (318) 346-3143 |